Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma
Clinical trial NCT02340936 · COMPLETED
Trial details
- NCT number
- NCT02340936
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2016-09-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.